New data suggests Veracyte’s RNA-Seq based Afirma GSC can help patients avoid unnecessary thyroid surgery

March 20, 2018 Leave a comment 3,143 Views

Veracyte, Inc. today announced that new data presented at ENDO 2018, the annual meeting of the Endocrine Society, suggest that the Afirma Genomic Sequencing Classifier (GSC) can help significantly more

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: ENDO 2018

New data suggests Veracyte’s RNA-Seq based Afirma GSC can help patients avoid unnecessary thyroid surgery

The Curated Cancer Cell Atlas – a comprehensive pan-cancer single-cell RNA-sequencing dataset

Single cell RNA-Seq and AI provide ‘crystal ball’ into leukaemia treatment-response

Unraveling the secrets of nerve regeneration: insights from RNA sequencing

New pan-cancer single-cell T cell atlas reveals new details of tumor microenvironment

scSemiAAE – a semi-supervised clustering model for single-cell RNA-seq data

Avidity Sequencing – high accuracy with low reagent consumption

scMEB – a fast and clustering-independent method for detecting differentially expressed genes in single-cell RNA-seq data